Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
70.04 USD | -0.74% | +2.15% | -1.99% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.99% | 1.27B | |
+25.62% | 661B | |
+26.74% | 566B | |
-6.64% | 352B | |
+19.92% | 332B | |
+3.02% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-5.30% | 145B |
- Stock Market
- Equities
- LGND Stock
- News Ligand Pharmaceuticals Incorporated
- Roth Capital Boosts Price Target on Ligand Pharmaceuticals to $90 From $85, Maintains Buy Rating